Literature DB >> 16919786

Role of the endocannabinoid system in depression and suicide.

K Yaragudri Vinod1, Basalingappa L Hungund.   

Abstract

Depression is one of the most prevalent forms of neuropsychiatric disorder and is a major cause of suicide worldwide. The prefrontal cortex is a crucial brain region that is thought to be involved in the regulation of mood, aggression and/or impulsivity and decision making, which are altered in suicidality. Evidence of the role of the endocannabinoid (EC) system in the neurobiology of neuropsychiatric disorders is beginning to emerge. The behavioral effects of ECs are believed to be mediated through the central cannabinoid CB1 receptor. Alterations in the levels of ECs, and in the density and coupling efficacy of CB1 receptors, have been reported in the prefrontal cortex of depressed and alcoholic suicide victims. These findings support our hypothesis that altered EC function contributes to the pathophysiological aspects of suicidal behavior. Here, we provide a brief overview of the role of the EC system in alcoholism, depression and suicide, and discuss possible therapeutic interventions and directions for future research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16919786     DOI: 10.1016/j.tips.2006.08.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  36 in total

Review 1.  In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans.

Authors:  Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11       Impact factor: 9.236

2.  Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.

Authors:  Matthew N Hill; Erica J Carrier; Ryan J McLaughlin; Anna C Morrish; Sarah E Meier; Cecilia J Hillard; Boris B Gorzalka
Journal:  J Neurochem       Date:  2008-07-15       Impact factor: 5.372

Review 3.  Smoking and suicide: a brief overview.

Authors:  John R Hughes
Journal:  Drug Alcohol Depend       Date:  2008-08-03       Impact factor: 4.492

Review 4.  The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders.

Authors:  Ismael Galve-Roperh; Javier Palazuelos; Tania Aguado; Manuel Guzmán
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-09       Impact factor: 5.270

5.  Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions.

Authors:  Mathieu Lafourcade; Thomas Larrieu; Susana Mato; Anais Duffaud; Marja Sepers; Isabelle Matias; Veronique De Smedt-Peyrusse; Virginie F Labrousse; Lionel Bretillon; Carlos Matute; Rafael Rodríguez-Puertas; Sophie Layé; Olivier J Manzoni
Journal:  Nat Neurosci       Date:  2011-01-30       Impact factor: 24.884

Review 6.  Cognitive enhancers for anxiety disorders.

Authors:  Stefan G Hofmann; Jasper A J Smits; Anu Asnaani; Cassidy A Gutner; Michael W Otto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-04       Impact factor: 3.533

7.  Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review.

Authors:  Laura Colino; Javier Herranz-Herrer; Elena Gil-Benito; Teresa Ponte-Lopez; Pablo Del Sol-Calderon; Maria Rodrigo-Yanguas; María Gil-Ligero; Antonio J Sánchez-López; Jose de Leon; Hilario Blasco-Fontecilla
Journal:  Curr Psychiatry Rep       Date:  2018-03-15       Impact factor: 5.285

8.  Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides.

Authors:  K Yaragudri Vinod; Suham A Kassir; Basalingappa L Hungund; Thomas B Cooper; J John Mann; Victoria Arango
Journal:  J Psychiatr Res       Date:  2009-12-16       Impact factor: 4.791

9.  Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression.

Authors:  Emmanuel S Onaivi; Hiroki Ishiguro; Jian-Ping Gong; Sejal Patel; Paul A Meozzi; Lester Myers; Alex Perchuk; Zoila Mora; Patricia A Tagliaferro; Eileen Gardner; Alicia Brusco; B Emmanuel Akinshola; Qing-Rong Liu; Sanika S Chirwa; Bruce Hope; Javier Lujilde; Toshiya Inada; Shinya Iwasaki; David Macharia; Lindsey Teasenfitz; Tadao Arinami; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Is cannabis a risk factor for suicide attempts in men and women with psychotic illness?

Authors:  A Waterreus; P Di Prinzio; J C Badcock; M Martin-Iverson; A Jablensky; V A Morgan
Journal:  Psychopharmacology (Berl)       Date:  2018-05-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.